Thomas Zhou, CBER/FDA

Thomas Zhou is a mathematical statistician at the FDA Center for Biologics Evaluation and Research (CBER), Division of Biostatistics. I received my Ph.D. in Biostatistics from Boston University, and has been with the FDA since 2021. My primary role at the FDA is to serve as the primary statistical reviewer on submissions and applications for biologic products, which include immunotherapy, cell therapy, gene therapy, biologic devices, and blood products. I have broad experience in the review of various disease indications, such as malignant hematology, neurology, ophthalmology, renal diseases, cardiovascular diseases, dermatology, and burn, wound and trauma. In my spare time, I enjoy hiking, running, and playing basketball and table tennis.